Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Chronic Central Serous Chorioretinitis
NCT01552044Phase 2Completed
- Sponsor
- Inserm
- Start
- Jan 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in Central Serous Chorioretinopathy (CSCR), sponsored by Inserm. Started Jan 2012; status: completed.
02
Drugs
spironolactone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01552044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552044.